Everand Logo

Welcome to Everand!

  • STAT

    My compulsive hair pulling and skin picking could be solved with a precision medicine approach

    Trichotillomania (hair-pulling disorder) and dermatillomania (skin-pulling disorder) are complex grooming-related mental illnesses. A precision medicine approach could identify the first effective treatment for them.
    by Kimi Vesel Aug 28, 2017 4 minutes
    Emily Bruce begin pulling out hairs from her head when she was 16. It took her nine years to tell her family and friends she had trichotillomania.

    President Obama’s call for the scientific community to embrace a precision medicine revolution gave me hope for some forward motion on two disorders I’ve quietly struggled with since my adolescence: trichotillomania and dermatillomania. Taking a precision medicine approach to these two conditions, which run under the radar of the medical establishment, could answer some longstanding clinical questions and potentially identify the first-ever effective treatments for them.

    Trichotillomania, also known as hair-pulling disorder, and its cousin, dermatillomania, or skin-pulling disorder, are grouped together with other related conditions as (BFRBs). These aren’t “bad habits.” Instead they are complex, grooming-related mental illnesses that cause people to inflict damage on their bodies in

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
    A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

    Related Books & Audiobooks